IL-23 provides a limited mechanism of resistance to acute toxoplasmosis in the absence of IL-12

被引:129
|
作者
Lieberman, LA
Cardillo, F
Owyang, AM
Rennick, DM
Cua, DJ
Kastelein, RA
Hunter, CA
机构
[1] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA
[2] Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil
[3] DNAX Res Inst Molec & Cellular Biol Inc, Discovery Res, Palo Alto, CA 94304 USA
来源
JOURNAL OF IMMUNOLOGY | 2004年 / 173卷 / 03期
关键词
D O I
10.4049/jimmunol.173.3.1887
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IL-23 and IL-12 are heterodimeric cytokines which share the p40 subunit, but which have unique second subunits, IL-23p19 and IL-12p35. Since p40 is required for the development of the Th1 type response necessary for resistance to Toxoplasma gondii, studies were performed to assess the role of IL-23 in resistance to this pathogen. Increased levels of IL-23 were detected in mice infected with T. gondii and in vitro stimulation of dendritic cells with this pathogen resulted in increased levels of mRNA for this cytokine. To address the role of IL-23 in resistance to T. gondii, mice lacking the p40 subunit (common to IL-12 and IL-23) and mice that lack IL-12 p35 (specific for IL-12) were infected and their responses were compared. These studies revealed that p40(-/-) mice rapidly succumbed to toxoplasmosis, while p35(-/-) mice displayed enhanced resistance though they eventually succumbed to this infection. In addition, the administration of IL-23 to p40(-/-) mice infected with T. gondii resulted in a decreased parasite burden and enhanced resistance. However, the enhanced resistance of p35(-/-) mice or p40(-/-) mice treated with IL-23 was not associated with increased production of IFN-gamma. When IL-23p19(-/-) mice were infected with T. gondii these mice developed normal T cell responses and controlled parasite replication to the same extent as wild-type mice. Together, these studies indicate that IL-12, not IL-23, plays a dominant role in resistance to toxoplasmosis but, in the absence of IL-12, IL-23 can provide a limited mechanism of resistance to this infection.
引用
收藏
页码:1887 / 1893
页数:7
相关论文
共 50 条
  • [1] IL-12 and IL-23 in health and disease
    Stetsko, Dawn
    Sauder, Daniel N.
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2008, 4 (03) : 301 - 303
  • [2] The Tale of IL-12 and IL-23: A Paradigm Shift
    Khader, Shabaana A.
    Thirunavukkarasu, Shyamala
    [J]. JOURNAL OF IMMUNOLOGY, 2019, 202 (03): : 629 - 630
  • [3] IL-23 and not IL-12 is essential for the development of IBD
    Hue, S
    Maloy, K
    McKensie, B
    Cua, D
    Powrie, F
    [J]. INFLAMMATORY BOWEL DISEASES, 2006, 12 : S25 - S25
  • [4] IL-12 and IL-23 Affect Photocarcinogenesis Differently
    Jantschitsch, Christian
    Weichenthal, Michael
    Proksch, Ehrhardt
    Schwarz, Thomas
    Schwarz, Agatha
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 (05) : 1479 - 1486
  • [5] IL-12 AND IL-23 SECRETION BY DENDRITIC CELLS IN SPONDYLOARTHROPATHY
    Prevosto, Claudia
    Goodall, Jane C.
    Gaston, Hill J.
    [J]. RHEUMATOLOGY, 2009, 48 : I6 - I6
  • [6] IL-23, not IL-12, Directs Autoimmunity to the Goodpasture Antigen
    Ooi, Joshua D.
    Phoon, Richard K. S.
    Holdsworth, Stephen R.
    Kitching, A. Richard
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 20 (05): : 980 - 989
  • [7] Influence of IL-23 and IL-12 on photo-carcinogenesis
    Jantschitsch, C.
    Maeda, A.
    Weichenthal, M.
    Schwarz, T.
    Schwarz, A.
    [J]. EXPERIMENTAL DERMATOLOGY, 2010, 19 (02) : 204 - 204
  • [8] Trabid epigenetically drives expression of IL-12 and IL-23
    Inna S Afonina
    Rudi Beyaert
    [J]. Nature Immunology, 2016, 17 : 227 - 228
  • [9] Trabid epigenetically drives expression of IL-12 and IL-23
    Afonina, Inna S.
    Beyaert, Rudi
    [J]. NATURE IMMUNOLOGY, 2016, 17 (03) : 227 - 228
  • [10] CHARACTERIZATION OF IL-12 AND IL-23 REDUCTION BY TOFACITINIB IN MDCS
    Vincken, N.
    Angiolilli, C.
    Cardoso, S.
    Lopes, A.
    Olde-Nordkamp, M.
    Radstake, T.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1328 - 1329